CM
AGN

CS McKee’s Allergan plc AGN Stock Holding History

CS McKee’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$5.84M Sell
30,531
-2,418
-7% -$436K 0.53% 53
2019
Q3 		$5.54M Sell
32,949
-5,238
-14% -$853K 0.5% 54
2019
Q2 		$6.39M Buy
38,187
+6,468
+20% +$896K 0.56% 54
2019
Q1 		$4.64M Buy
31,719
+200
+0.6% +$29K 0.41% 58
2018
Q4 		$4.21M Hold
31,519
– – 0.42% 59
2018
Q3 		$6M Sell
31,519
-500
-2% -$91.9K 0.48% 56
2018
Q2 		$5.34M Sell
32,019
-5,930
-16% -$952K 0.45% 60
2018
Q1 		$6.39M Sell
37,949
-346
-0.9% -$58K 0.5% 60
2017
Q4 		$6.26M Buy
38,295
+254
+0.7% +$45.6K 0.47% 62
2017
Q3 		$7.8M Sell
38,041
-604
-2% -$140K 0.6% 55
2017
Q2 		$9.39M Sell
38,645
-563
-1% -$132K 0.75% 52
2017
Q1 		$9.37M Sell
39,208
-8,009
-17% -$1.87M 0.75% 51
2016
Q4 		$9.92M Sell
47,217
-26,325
-36% -$5.45M 0.76% 53
2016
Q3 		$16.9M Sell
73,542
-77,883
-51% -$19M 1.08% 42
2016
Q2 		$35M Sell
151,425
-22,477
-13% -$5.18M 1.5% 32
2016
Q1 		$46.6M Sell
173,902
-17,959
-9% -$5.14M 1.71% 26
2015
Q4 		$60M Sell
191,861
-10,155
-5% -$3.02M 1.91% 16
2015
Q3 		$54.9M Sell
202,016
-15,134
-7% -$4.65M 1.78% 16
2015
Q2 		$65.9M Sell
217,150
-15,778
-7% -$4.71M 1.83% 20
2015
Q1 		$69.3M Sell
232,928
-19,899
-8% -$5.67M 1.81% 21
2014
Q4 		$65.1M Sell
252,827
-14,827
-6% -$3.71M 1.57% 30
2014
Q3 		$64.6M Sell
267,654
-23,518
-8% -$5.26M 1.48% 29
2014
Q2 		$61.4M Sell
291,172
-9,395
-3% -$1.95M 1.3% 35
2014
Q1 		$61.9M Sell
300,567
-48,441
-14% -$9.6M 1.33% 35
2013
Q4 		$58.6M Buy
349,008
+347,808
+28,984% +$54.4M 1.15% 39
2013
Q3 		$173K Buy
+1,200
New +$160K ﹤0.01% 121

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CS McKee's AGN Position: Q4 2019 in Review

CS McKee reduced its Allergan plc (AGN) stake by 7.3% in Q4 2019, selling an estimated $436K and leaving 30,531 shares worth $5.84M. The position accounts for 0.53% of the portfolio, ranked #53.

CS McKee first reported a position in AGN in Q3 2013 and has held it in 26 quarters since. The position peaked at $69.3M in Q1 2015. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • CS McKee held 30,531 shares of Allergan plc worth $5.84M as of Q4 2019.
  • CS McKee sold 2,418 Allergan plc shares in Q4 2019, an estimated $436K.
  • Allergan plc made up 0.53% of CS McKee's portfolio in Q4 2019, its #53 holding.
  • CS McKee first reported a position in Allergan plc in Q3 2013 and has held it in 26 quarters since.
  • CS McKee's Allergan plc position peaked at $69.3M in Q1 2015.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on CS McKee's 13F filing for Q4 2019, filed 14 Feb 2020.